OCT 5 ~ 2005
LOSQRLEE
a
510(k) Summary
ArthroCare Corporation ? , , 6 p , )
ArthroCare ArthroWands “a 4, a

General Information :
Submitter Name/Address: ArthroCare Corporation

680 Vaqueros Avenue

Sunnyvale, CA 94085-3523
Establishment Registration Number: 2951580
Contact Person: Valerie Defiesta-Ng

Director, Regulatory Affairs
Date Prepared: September 27, 2005
Device Description
Trade Name: ArthroCare® ArthroWands®
Generic/Common Name: Electrosurgical Device and Accessories
Classification Name: Electrosurgical Cutting and Coagulation

Device and Accessories (21 CFR 878.4400)
Predicate Devices
a tecicate cvices
ArthroCare” ArthroWands* K020557, K033584
Product Description
The ArthroCare ArthroWands are bipolar, single use, high frequency electrosurgical
devices designed for specific indications in arthroscopic and orthopedic procedures.

xii

KOS RQ& vb
Ne
’ 2. +t, @
Intended Uses ji “
The ArthroCare ArthroWands are indicated for resection, ablation, and coagulation of
soft tissue and hemostasis of blood vessels in arthroscopic and orthopedic procedures:
Joint Specific or All
Arthroscopic and Orthopedic Procedures Joints (ankle, elbow,
hip, knee, shoulder, and
wrist
= Articular Labrum
xiii

KOS Abae ge Qe
Continued ,
o Joint Specific or All
. . Joints (ankle, elbow,
Arthroscopic and Orthopedic Procedures hip, knee, shoulder, and
wrist
Substantial Equivalence
This Special 510(k) proposes modifications in performance specifications, labeling, and
packaging configuration for the ArthroCare ArthroWands, which were previously cleared
in K020557 (March 21, 2002) and K033584 (November 28, 2003). The indications for
use, technology, principle of operation, and sterilization parameters of the ArthroCare
ArthroWands remain the same as in the predicate cleared 510(k)s.
Summary of Safety and Effectiveness
The modified ArthroCare ArthroWands, as described in this Special 510(k), are
substantially equivalent to the predicate device. The proposed modifications in the
performance specifications, labeling, and packaging configuration are not substantial
changes or modifications, and do not significantly affect the safety or efficacy of the
devices.
XIV

f C DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
woe Food and Drug Administration
OCT 6 - 2005 9200 Corporate Boulevard
Rockville MD 20850

Ms. Valerie DeFiesta-Ng
Director, Regulatory Affairs
ArthroCare Corporation
680 Vaqueros Avenue
Sunnyvale, California 94085-3523
Re: K052686

Trade/Device Name: ArthroCare” Arthro Wands”

Regulation Number: 21 CIR 878.4400

Regulation Name: Electrosurgical cutting and coagulation device and accessories

Regulatory Class: 1]

Product Code: GEI

Dated: September 27, 2005

Received: September 28, 2005
Dear Ms. DeFiesta-Ng:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class If (Special Controls) or class II] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complics with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation contro] provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2- Ms. Valerie DeFiesta-Ng
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (2] CFR Part 801), please
contact the Office of Compliance at (240) 276-0115. Also, please note the regulation entitled,
"Misbranding by reference to premarkct notification” (21CFR Part 807.97). You may obtain
other genera! information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www.fda.gov/edrh/dsma/dsmamain.html

Sincerely yours,

Any bee Pouctudt>
OE Voir uch

Mark N. Melkerson

Acting Director

Division of General, Restorative

and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health

Enclosure

Indications for Use Statement p
401 4, @
510(k) Number: KOS 2646 é
Device Name ArthroCare® ArthroWands®
Indications for Use:
The ArthroCare ArthroWands are indicated for resection, ablation, and coagulation of
soft tissue and hemostasis of blood vessels in arthroscopic and orthopedic procedures:
‘| Joint Specific or AH
Arthroscopic and Orthopedic Procedures... | Joints (ankle, elbow, «>
: : : : -1° hip, knee, shoulder, and.
oo : SP wrist) 60006 se
Ablation and Debridement
fs acLPGR CCS Kee
Shoulder
¢ — Articular Cartilage All Joints
[+ Bursectomy All Joints
« —Chondroplast All Joints
fe Faia C—O A Joints
fe Ligament Alt Joints
pe Notchplasty Kee
fe Scar Tissue its |
f+ SoftTisue All Joints
¢ —Subacromial Decompression Shoulder
+__ Synovectom
fs Tendon SSCSsCSC‘Csi‘S A Joints
¢_Articular Labrum
= Capsule
*__ Capsular Release
+ Cysts
+ _Discoid Meniscus
¢ Frozen Shoulder Release Shoulder
+ Glenoidale Labrum
+ Ligament
¢ Loose Bodies All Joints
J+ Meniscal Cystectomy Knee
LTY¥ U b>! o.
Division of General, Restorative,
Neurological Devices
: _ ‘ x
S10) Number KOS 24U€¥ 
lege 2
Kosa bgt dt 4 @)
7
Continued
: : ~ Joint Specific or All
. : Joints (ankle, elbow,
Arthroscopic and Orthopedic Procedures hip, knee, shoulder, and
wrist
All Joints
All Joints
¢ Triangular Fibrocartilage (TFCC
Coagulation
© ACLPEL
¢  Glenohumeral Capsule Shoulder
All Joints
+ _ Medial Retinaculum
Shoulder
+__Tendon _
¢_Wrist Tendons
Prescription Use x AND/OR — Over-The-Counter Use
(Part 21 CFR 801 Subpart D) (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
oot a [ssl
Division of General, Restorative,
and Neurological Devices
510(k) Number_KOS 2086
xi 
